Fresenius Medical Care

In 2010, the focus was on reorganizing the global procurement processes within the newly created Global Manufacturing Operations (GMO). division in order to coordinate the competencies in manufacturing methods and processes, quality management, strategic sourcing, and supply chain management closely within Fresenius Medical Care. The aim is

  • to make processes and procedures still more efficient
  • to control risks and costs more effectively
  • to further increase the profitability of the manufacturing operations

In 2010, we examined the extent to which the production plants in the regions can supply each other with finished products and intermediate goods. This applies to products that can be adapted to local requirements but are based on standardized core materials and technologies, enabling manufacturing capacities to be employed more flexibly and thus more efficiently on a global basis.

The GMO division monitors developments on the global procurement markets and in key currencies. The aim is to exploit international price advantages when sourcing raw materials and components for production while at the same time achieving a better spread of the related risks, e. g. potential costs of currency movements or dependencies on individual suppliers.

All of our locations need to be supplied with raw materials and components of consistent high quality. We are therefore sourcing increasingly from suppliers who operate internationally and have production capacities throughout the world. In 2010, GMO supplemented the existing supplier management system by integrating a new risk management process. This monitors the relations with strategic suppliers on the basis of standardized criteria. These criteria include the solvency of our suppliers, their short and mid-term supply capacity, and possible monopoly positions as well as currency risks and quality risks.

Back to:
Continue reading:
Fresenius Kabi



External related links

Internal related Links